Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127684171 | 12768417 | 1 | I | 20130805 | 20160915 | 20160921 | 20160921 | EXP | AU-ABBVIE-16P-008-1734528-00 | ABBVIE | 29.00 | YR | M | Y | 0.00000 | 20160921 | CN | AU | AU |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127684171 | 12768417 | 1 | PS | VALPROATE SODIUM. | VALPROATE SODIUM | 1 | Oral | U | UNKNOWN | 18081 | 600 | MG | BID | ||||||
| 127684171 | 12768417 | 2 | SS | CLOZARIL | CLOZAPINE | 1 | Oral | U | UNKNOWN | 0 | QD | ||||||||
| 127684171 | 12768417 | 3 | SS | CLOZARIL | CLOZAPINE | 1 | Oral | U | UNKNOWN | 0 | BID | ||||||||
| 127684171 | 12768417 | 4 | C | NODOZ | CAFFEINE | 1 | 0 | ||||||||||||
| 127684171 | 12768417 | 5 | C | ATENOLOL. | ATENOLOL | 1 | 0 | ||||||||||||
| 127684171 | 12768417 | 6 | C | CHLORPROMAZINE. | CHLORPROMAZINE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127684171 | 12768417 | 1 | Product used for unknown indication |
| 127684171 | 12768417 | 2 | Schizophrenia |
| 127684171 | 12768417 | 4 | Product used for unknown indication |
| 127684171 | 12768417 | 5 | Product used for unknown indication |
| 127684171 | 12768417 | 6 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127684171 | 12768417 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127684171 | 12768417 | Alanine aminotransferase increased | |
| 127684171 | 12768417 | Aspartate aminotransferase increased | |
| 127684171 | 12768417 | Blood bilirubin increased | |
| 127684171 | 12768417 | Blood lactate dehydrogenase decreased | |
| 127684171 | 12768417 | Gamma-glutamyltransferase increased | |
| 127684171 | 12768417 | Mental impairment | |
| 127684171 | 12768417 | Neutropenia | |
| 127684171 | 12768417 | Paranoia | |
| 127684171 | 12768417 | Psychotic disorder | |
| 127684171 | 12768417 | Sleep disorder | |
| 127684171 | 12768417 | White blood cell disorder |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127684171 | 12768417 | 2 | 20091029 | 0 |